 COPENHAGEN, Denmark, March 04, 2021 GLOBE NEWSWIRE -- Ascendis Pharma AS Nasdaq: ASND, a biopharmaceutical company that utilizes its innovative TransConTM technologies to create product candidates that address unmet medical needs, today announced that the company will hold a conference call and live webcast on Wednesday, March 10, 2021 at 4:30 p.m. Eastern Time ET to review its 2020 financial results and provide a business update. 